Renaissance Technologies’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SM
Renaissance Technologies's MTRI Position: Q4 2025 in Review
Renaissance Technologies sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2025, closing a stake of 1,680 shares — an estimated $36.8K sold.
Renaissance Technologies first reported a position in MTRI in Q4 2021 and held it in 8 quarters. The position peaked at $84K in Q1 2023. 6 funds tracked by Wall St. Rank hold MTRI as of Q4 2025.
- Renaissance Technologies reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2025 after selling out during the quarter.
- Renaissance Technologies sold 1,680 Mentari Therapeutics, Inc. Common Stock shares in Q4 2025, an estimated $36.8K.
- Renaissance Technologies first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
- Renaissance Technologies's Mentari Therapeutics, Inc. Common Stock position peaked at $84K in Q1 2023.
- 6 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.